Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line

BACKGROUND: Angiogenesis is critical for the growth and metastasis of solid tumors and is, therefore, an important therapeutic target. Despite the great research advances in tumor therapies targeting vascular endothelial growth factor (VEGF), drug resistance frequently occurs, and further strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaofeng, Yan, Yuhua, Xun, Qingying, Shi, Jiayu, Kong, Xiangyi, Wu, Jun, Zhou, Huaijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388957/
https://www.ncbi.nlm.nih.gov/pubmed/30863089
http://dx.doi.org/10.2147/OTT.S194064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388957/
https://www.ncbi.nlm.nih.gov/pubmed/30863089
http://dx.doi.org/10.2147/OTT.S194064

Ejemplares similares